Stoltze L, Dick T P, Deeg M, Pömmerl B, Rammensee H G, Schild H
Institute for Cell Biology, Department of Immunology, University of Tübingen, Germany.
Eur J Immunol. 1998 Dec;28(12):4029-36. doi: 10.1002/(SICI)1521-4141(199812)28:12<4029::AID-IMMU4029>3.0.CO;2-N.
The proteasome is involved in the generation of most of the MHC class I antigenic epitopes. However, it is not known if the proteasome generates the exact cytotoxic T lymphocyte (CTL) epitope or only epitope precursors which require further modification by additional proteases. Digestion of the extended vesicular stomatitis virus nucleoprotein epitope 52-59 (RGYVYQGL) by the 20S proteasome in vitro shows that the proteasome is capable of generating the correct C terminus but not the exact N terminus of the CTL epitope. This finding suggests that proteolytic activity in addition to the proteasome is required for generation of the CTL epitope. By using the proteasome inhibitor lactacystin we were able to confirm this finding in vivo. Lactacystin prevented the processing of N- and C-terminally extended epitopes, whereas the processing of only N-terminally extended epitopes was unaffected. Thus, the proteasome is necessary and sufficient for the generation of the exact C terminus of this CTL epitope, whereas the exact N terminus seems to be generated by a different protease.
蛋白酶体参与了大多数MHC I类抗原表位的产生。然而,尚不清楚蛋白酶体产生的是确切的细胞毒性T淋巴细胞(CTL)表位,还是仅产生需要额外蛋白酶进一步修饰的表位前体。20S蛋白酶体在体外对延伸的水疱性口炎病毒核蛋白表位52 - 59(RGYVYQGL)进行消化,结果表明蛋白酶体能够产生正确的C末端,但不能产生CTL表位确切的N末端。这一发现表明,除蛋白酶体外,还需要蛋白水解活性来产生CTL表位。通过使用蛋白酶体抑制剂乳胞素,我们能够在体内证实这一发现。乳胞素可阻止N末端和C末端延伸表位的加工,而仅N末端延伸表位的加工不受影响。因此,蛋白酶体对于产生该CTL表位的确切C末端是必要且充分的,而确切的N末端似乎是由另一种蛋白酶产生的。